# Biparametric MRI in Prostate Cancer Screening: a Noninferior Randomized Controlled Study

> **NCT05025527** · NA · UNKNOWN · sponsor: **Shanghai East Hospital** · enrollment: 500 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DIAGNOSTIC_TEST:** biparametric MRI (bpMRI)
- **DIAGNOSTIC_TEST:** Prostate cancer antigen (PSA)

## Key facts

- **NCT ID:** NCT05025527
- **Lead sponsor:** Shanghai East Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-01
- **Primary completion:** 2024-12-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2022-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05025527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05025527, "Biparametric MRI in Prostate Cancer Screening: a Noninferior Randomized Controlled Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05025527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*